We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

The Surgeon and Surgical Procedure as Prognostic Factors

Dec 1, 1997
Volume: 
11
Issue: 
12
  • Colorectal Cancer

Surgical oncology themes at the 1997 European Cancer Conference (ECCO 9) included the need for meticulous surgery and the need for surgeons to develop and implement guidelines for the management of cancer.

For example, Professor Werner Hohenberger of the University Hospital, Erlanger, Germany, presented evidence showing that patients treated surgically for colorectal cancer do best if their surgeon follows a quality management program (practice guidelines). However, he also emphasized that other factors, such as which surgeon operates and in which institution the operation is performed, can also be vitally important.

He explained: “We studied patients with colorectal cancer who were treated in seven German institutions and followed up for at least 5 years, and the results of our study show that adhering to the steps of a quality management program is the most important factor to influence long-term outcome after surgery.”

“However,” Professor Hohenberger continued, “as far as locoregional recurrences were concerned, we found that the institution where the operations took place had an independent effect on the outlook and that in three institutions where the surgeons performed more than 100 operations in the recruitment period, individual surgeons could be identified as a prognostic factor.”

“From the data available, we conclude that centralization, specialization, and volume of surgery do not in themselves guarantee high quality, but it seems important for surgeons to have a certain amount of experience, and a special interest in the field may be a basic requisite for good outcome. However, adherence to the steps of a quality program is the most important factor to influence outcome.”

Professor Hohenberger’s conclusions about the importance of following standardized procedures were echoed by Professor Markus Büchler of the Department of Visceral and Transplantation Surgery, University Hospital, Bern, Switzerland.

“Recent data show a significant drop in mortality for major pancreatic resections for cancer. To find the reason for this, we reviewed 152 patients with pancreatic cancer and concluded that, in a specialist center with standardized preoperative assessment and operative technique combined with experience, even patients with preoperative risk factors can undergo major pancreatic surgery with good results.”

Related Articles

  • Inhibit CXCR4 to Treat CRC and Pancreatic Cancer
  • ACS Nutrition, Activity Guidelines Boost Survival in Stage III CRC
  • Modified XELIRI Noninferior to FOLFIRI for Metastatic CRC
  • A3AR Agonists May Help Prevent Chemotherapy-Induced Neuropathic Pain
  • Less Risk of Distal Colon Cancer With Lower Red Meat Intake?

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.